Ressources

We report on perceptions of discrimination from the perspectives of patients with chronic non-cancer pain (CNCP) and a history of substance use and their clinicians within the structural landscape

To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time.

The current study examines the differential geography of opioid overdose death (OOD) by race and time (i.e., pre-fentanyl versus fentanyl era) in St. Louis, Missouri.

The aims of the study are to review the current research on the association between access to medications for opioid use disorders (MOUD) and race, to identify gaps in research methods, and to prop

The present study examines the longitudinal effects of a regional patient choice reform which substantially increased availability to opioid maintenance treatment in one Swedish county, starting fr

This study seeks to understand the general adult population’s knowledge, attitudes, and stigma towards methamphetamine use and people with a history of methamphetamine use.

We aimed to assess the effect of methadone on non-opioid substance use compared to buprenorphine/naloxone (BUP/NX), to explore whether non-opioid substance use is associated with opioid use and ret

Assess the preliminary impact of Brave Technology Co-op’s overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North

We conducted a retrospective cohort study of EMS patients who survived a prior opioid overdose in 2019-2021 in King County, Washington.

We evaluated the effectiveness of a Two-Eyed Seeing approach in a four-week harm reduction residential treatment programme for clients with a history of substance use disorder (SUD) and intergenera

We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to medications to treat opioid use disorder (MOUD, ie, buprenorphine, met

Patients in treatment with medications for opioid use disorder (MOUD) often report use of other substances in addition to opioids.